Skip to main content
Top
Published in: Rheumatology International 5/2011

01-05-2011 | Original Article

Quality of life in patients with ankylosing spondylitis: relationships with spinal mobility, disease activity and functional status

Author: Oya Özdemir

Published in: Rheumatology International | Issue 5/2011

Login to get access

Abstract

The aim of this study was to evaluate quality of life (QOL) in patients with ankylosing spondylitis (AS) and to determine the relationships between QOL and clinical variables including spinal mobility, disease activity and functional status. Forty-eight adult patients who fulfilled the modified New York criteria for AS were included in the study. After detailed physical examination, disease-specific instruments: the Bath ankylosing spondylitis disease activity index (BASDAI) and the Bath ankylosing spondylitis functional index (BASFI) were applied. QOL was assessed using short form-36 (SF-36). The mean age of the patients was 37.0 ± 9.7 years and the mean duration of symptoms was 11.7 ± 8.4 years. Most affected domains of SF-36 were bodily pain, vitality, and physical role, respectively. No significant correlations were found between SF-36 subgroup scores and chest expansion, wall–tragus distance, chin–sternum distance, and floor–finger tip distance. Only modified Schober correlated with two SF-36 domains: physical role and bodily pain. BASDAI and BASFI scores had significant negative correlations with all SF-36 domains except for general health. Identification of QOL in patients with AS is very important in evaluation of illness-related sufferings and development of new management strategies.
Literature
1.
go back to reference Boulware DW, Arnett FC, Cush JJ, Bennett RM, Mielants H, De Keyser F, Veys EM (2003) The seronegative spondyloarthropathies. In: Koopman WJ, Boulware DW, Heudebert GR (eds) Clinical primer of rheumatology. Lippincott, Williams and Wilkins, Philadelphia, pp 127–163 Boulware DW, Arnett FC, Cush JJ, Bennett RM, Mielants H, De Keyser F, Veys EM (2003) The seronegative spondyloarthropathies. In: Koopman WJ, Boulware DW, Heudebert GR (eds) Clinical primer of rheumatology. Lippincott, Williams and Wilkins, Philadelphia, pp 127–163
2.
go back to reference Ward MM (1998) Quality of life in patients with ankylosing spondylitis. Rheum Dis Clin North Am 24:815–827PubMedCrossRef Ward MM (1998) Quality of life in patients with ankylosing spondylitis. Rheum Dis Clin North Am 24:815–827PubMedCrossRef
3.
go back to reference Ozgul A, Peker F, Taskaynatan MA, Tan AK, Dinçer K, Kalyon TA (2006) Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. Clin Rheumatol 25:168–174PubMedCrossRef Ozgul A, Peker F, Taskaynatan MA, Tan AK, Dinçer K, Kalyon TA (2006) Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. Clin Rheumatol 25:168–174PubMedCrossRef
4.
go back to reference Dagfinrud H, Mengshoel AM, Hagen KB, Loge JH, Kvien TK (2004) Health status of patients with ankylosing spondylitis: a comparison with the general population. Ann Rheum Dis 63:1605–1610PubMedCrossRef Dagfinrud H, Mengshoel AM, Hagen KB, Loge JH, Kvien TK (2004) Health status of patients with ankylosing spondylitis: a comparison with the general population. Ann Rheum Dis 63:1605–1610PubMedCrossRef
5.
go back to reference Fitzpatrick R (1993) The measurement of health status and quality of life in rheumatologic disorders. Baillieres Clin Rheumatol 7:297–317PubMedCrossRef Fitzpatrick R (1993) The measurement of health status and quality of life in rheumatologic disorders. Baillieres Clin Rheumatol 7:297–317PubMedCrossRef
6.
go back to reference Ortiz Z, Shea B, Garcia Dieguez M, Boers M, Tugwell P, Boonen A, Wells G (1999) The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trials. J Rheumatol 26:210–216PubMed Ortiz Z, Shea B, Garcia Dieguez M, Boers M, Tugwell P, Boonen A, Wells G (1999) The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trials. J Rheumatol 26:210–216PubMed
7.
go back to reference Ward MM (1999) Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res 12:247–255PubMedCrossRef Ward MM (1999) Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res 12:247–255PubMedCrossRef
8.
go back to reference Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T, Westlake L (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305:160–164PubMedCrossRef Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T, Westlake L (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305:160–164PubMedCrossRef
9.
go back to reference Husted JA, Gladman DD, Farewell VT, Long JA, Cook RJ (1997) Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 24:511–517PubMed Husted JA, Gladman DD, Farewell VT, Long JA, Cook RJ (1997) Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 24:511–517PubMed
10.
go back to reference Chorus AM, Miedema HS, Boonen A, Van der Linden S (2003) Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis 62:1178–1184PubMedCrossRef Chorus AM, Miedema HS, Boonen A, Van der Linden S (2003) Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis 62:1178–1184PubMedCrossRef
11.
go back to reference Ariza-Ariza R, Hernández-Cruz B, Navarro-Sarabia F (2003) Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis. Arthritis Rheum 49:483–487PubMedCrossRef Ariza-Ariza R, Hernández-Cruz B, Navarro-Sarabia F (2003) Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis. Arthritis Rheum 49:483–487PubMedCrossRef
12.
go back to reference Turan Y, Duruöz MT, Cerrahoglu L (2007) Quality of life in patients with ankylosing spondylitis: a pilot study. Rheumatol Int 27:895–899PubMedCrossRef Turan Y, Duruöz MT, Cerrahoglu L (2007) Quality of life in patients with ankylosing spondylitis: a pilot study. Rheumatol Int 27:895–899PubMedCrossRef
13.
go back to reference Vesović-Potić V, Mustur D, Stanislavljević D, Ille T, Ille M (2009) Relationship between spinal mobility measures and quality of life in patients with ankylosing spondylitis. Rheumatol Int 29:879–884PubMedCrossRef Vesović-Potić V, Mustur D, Stanislavljević D, Ille T, Ille M (2009) Relationship between spinal mobility measures and quality of life in patients with ankylosing spondylitis. Rheumatol Int 29:879–884PubMedCrossRef
14.
go back to reference Bostan EE, Borman P, Bodur H, Barça N (2003) Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 23:121–126PubMed Bostan EE, Borman P, Bodur H, Barça N (2003) Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 23:121–126PubMed
15.
go back to reference Hamdi W, Azzouz D, Saadellaoui K, Daoud L, Kochbati S, Ben Hamida A, Zouari B, Kochir MM (2007) Correlations between Bath ankylosing spondylitis metrology index (BASMI), functional, structural, enthesopathy, disease activity index, and quality of life in 120 patients with ankylosing spondylitis. Ann Rheum Dis 66(Suppl 2):398 Hamdi W, Azzouz D, Saadellaoui K, Daoud L, Kochbati S, Ben Hamida A, Zouari B, Kochir MM (2007) Correlations between Bath ankylosing spondylitis metrology index (BASMI), functional, structural, enthesopathy, disease activity index, and quality of life in 120 patients with ankylosing spondylitis. Ann Rheum Dis 66(Suppl 2):398
16.
go back to reference Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–381PubMedCrossRef Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–381PubMedCrossRef
17.
go back to reference Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in AS: the Bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in AS: the Bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291PubMed
18.
go back to reference Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in AS: the development of the Bath ankylosing spondylitis functional index. J Rheumatol 21:2281–2285PubMed Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in AS: the development of the Bath ankylosing spondylitis functional index. J Rheumatol 21:2281–2285PubMed
19.
go back to reference Akkoç Y, Karatepe AG, Akar S, Kirazlı Y, Akkoç N (2005) A Turkish version of the Bath ankylosing spondylitis disease activity index: reliability and validity. Rheumatol Int 25:280–284PubMedCrossRef Akkoç Y, Karatepe AG, Akar S, Kirazlı Y, Akkoç N (2005) A Turkish version of the Bath ankylosing spondylitis disease activity index: reliability and validity. Rheumatol Int 25:280–284PubMedCrossRef
20.
go back to reference Yanık B, Gürsel YK, Kutlay Ş, Ay S, Elhan AH (2005) Adaptation of the BASFI to the Turkish population, its reliability and validity: functional assessment in AS. Clin Rheumatol 24:41–47PubMedCrossRef Yanık B, Gürsel YK, Kutlay Ş, Ay S, Elhan AH (2005) Adaptation of the BASFI to the Turkish population, its reliability and validity: functional assessment in AS. Clin Rheumatol 24:41–47PubMedCrossRef
21.
go back to reference Koçyiğit H, Aydemir Ö, Fişek G, Ölmez N, Memiş A (1999) Kısa Form-36 (SF-36)’nın Türkçe versiyonunun güvenilirliği ve geçerliliği. Romatizmal hastalığı olan bir grup hasta ile çalışma. İlaç ve Tedavi Dergisi 12:102–106 Koçyiğit H, Aydemir Ö, Fişek G, Ölmez N, Memiş A (1999) Kısa Form-36 (SF-36)’nın Türkçe versiyonunun güvenilirliği ve geçerliliği. Romatizmal hastalığı olan bir grup hasta ile çalışma. İlaç ve Tedavi Dergisi 12:102–106
22.
go back to reference Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRef Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRef
23.
go back to reference Hays RD, Hahn H, Marshall G (2002) Use of the SF-36 and other health-related quality of life measures to assess persons with disabilities. Arch Phys Med Rehabil 83(Suppl 2):S4–S9PubMedCrossRef Hays RD, Hahn H, Marshall G (2002) Use of the SF-36 and other health-related quality of life measures to assess persons with disabilities. Arch Phys Med Rehabil 83(Suppl 2):S4–S9PubMedCrossRef
24.
go back to reference Martindale J, Smith J, Sutton CJ, Grennan D, Goodacre L, Goodacre JA (2006) Disease and psychological status in ankylosing spondylitis. Rheumatology (Oxford) 45:1288–1293CrossRef Martindale J, Smith J, Sutton CJ, Grennan D, Goodacre L, Goodacre JA (2006) Disease and psychological status in ankylosing spondylitis. Rheumatology (Oxford) 45:1288–1293CrossRef
25.
go back to reference Ruof J, Stucki G (1999) Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 26:966–970PubMed Ruof J, Stucki G (1999) Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 26:966–970PubMed
26.
go back to reference Spoorenberg A, van Heijde D, Klerk E, Dougados M, de Vlam K, Mielants H, van der Tempel H, van der Linden S (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980–984PubMed Spoorenberg A, van Heijde D, Klerk E, Dougados M, de Vlam K, Mielants H, van der Tempel H, van der Linden S (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26:980–984PubMed
27.
go back to reference Ware JE Jr (2000) SF-36 health survey update. Spine (Phila Pa 1976) 25:3130–3139 Ware JE Jr (2000) SF-36 health survey update. Spine (Phila Pa 1976) 25:3130–3139
28.
go back to reference Ward MM, Weisman MH, Davis JC Jr, Reveille JD (2005) Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis Rheum 53:710–717PubMedCrossRef Ward MM, Weisman MH, Davis JC Jr, Reveille JD (2005) Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis Rheum 53:710–717PubMedCrossRef
29.
go back to reference Cella D, Nowinski CJ (2002) Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system. Arch Phys Med Rehabil 83(Suppl 2):S10–S17PubMedCrossRef Cella D, Nowinski CJ (2002) Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system. Arch Phys Med Rehabil 83(Suppl 2):S10–S17PubMedCrossRef
Metadata
Title
Quality of life in patients with ankylosing spondylitis: relationships with spinal mobility, disease activity and functional status
Author
Oya Özdemir
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1328-2

Other articles of this Issue 5/2011

Rheumatology International 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine